Sr. Director | BU Commercial Lead, AI Applications @ (January 2024 - August 2025)
Head of Commercial, MultiOmics @ (September 2022 - March 2024)
Sr. Director | BU Commercial Lead, Therapies @ (February 2020 - September 2022)
Sr. Commercial Manager, Clinical Trials Business @ (January 2019 - January 2020)
VP Business Development @ (January 2017 - January 2019)
Advisor @ (September 2017 - September 2018)
Director, Key Accounts @ (January 2010 - January 2017)
Greg Bryant Education
The Wharton School
Chief Revenue Officer (CRO) Program
2025-2026
Kaplan Business School
Applied Finance
2008-2010
RMIT University
Bachelor of Business (Finance)
Greg Bryant Skills
Market Analysis
Analytics
Account Management
Mergers and Acquisitions
Business Analysis
Financial Reporting
Sales Management
Strategic Planning
Microsoft Office
Data Analysis
Management
Pharmaceutical Industry
Leadership
Competitive Analysis
Life Sciences
Customer Relationship Management Crm
Licensing
Biotechnology
Sales
CRM
Strategy
B2b
Commercialization
Drug Development
Competitive Intelligence
New Business Development
Marketing
Salesforce.com
Business Valuation
Marketing Strategy
Pharmaceutical Sales
Business Strategy
Business Development
Consulting
International Business Development
Sales Strategy
Clinical Trials
Mobile Health
Deal Closure
Start Ups
Entrepreneurship
Clinical Development
Sales and Marketing Leadership
Digital Health
Customer Relationship Management
Greg Bryant Summary
Greg Bryant, based in Melbourne, VIC, AU, is currently a Chief Commercial Officer at Bevimi. Greg Bryant brings experience from previous roles at Tempus AI and 23andMe. Greg Bryant holds a 2025 - 2026 Chief Revenue Officer (CRO) Program @ The Wharton School. With a robust skill set that includes Market Analysis, Analytics, Account Management, Mergers and Acquisitions, Business Analysis and more. Greg Bryant has 1 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Greg Bryant?
Find contact details for 700 million professionals.